Portfolios

Improving BioTech Incubator Collaboration, Traction and Agility

M:M Bio, a collaborative ecosystem of oncology and immuno-oncology biotechs based in Oxford, wanted to revolutionize its approach to drug discovery and R&D. With companies ranging from early-stage discovery to clinical development, the organization needed to improve how teams worked together, manage long lead times, and pivot quickly based on experimental data—all while keeping their shared vision of accelerating breakthrough therapies.


When/Why

M:M Bio was embarking on several strategic initiatives, including accelerating small molecule development, streamlining the transition from laboratory discovery to clinical trials, and establishing a transparent, collaborative culture across its portfolio companies. The inherent uncertainties in drug discovery and the pressure to deliver life-changing treatments faster made adopting a new way of working critical. The urgency increased as the competitive landscape in oncology and immuno-oncology demanded rapid iteration and robust risk management.


Options

Before embracing Agile, M:M Bio relied on traditional project management approaches, often leading to siloed communication and slow feedback loops. These methods struggled under the weight of complex research timelines, external manufacturing dependencies, and the unpredictable nature of scientific experimentation. Recognizing the need for a more adaptive and collaborative framework, M:M Bio chose to work with me based on my focus on helping leaders apply Professional Scrum and Agile principles beyond in complex multidisciplinary environments – way beyond the traditional IT environments where agile was developed.


Success

M:M Bio set its sights on faster, more reliable decision-making and improved collaboration across R&D, clinical operations, and external partners. Early successes included streamlined project kick-offs, more effective risk management, and visible progress on key drug discovery milestones. By introducing Agile practices, teams became more proactive, leading to:

  • Reduced rework and delays through early identification of risks.
  • Enhanced transparency with shared Kanban boards and iterative feedback.
  • A cultural shift that empowered scientists to experiment, learn, and adapt rapidly.

Path to Success

M:M Bio chose to tackle its complex R&D challenges by adopting a hybrid Agile approach that blended traditional planning with Scrum and Kanban practices. The engagement began with a strategic workshop I led, where cross-functional teams—including scientists, project managers, and operational leaders—learned how to align Agile principles with the unique demands of drug discovery. The journey included:

  • Foundational Training: Establishing a common language around Agile to ensure all teams understood the new methodologies.
  • Pilot Projects: Launching multiple pilots across different companies and project types to refine the approach.
  • Iterative Improvement: Using regular retrospectives to adjust workflows and balance the need for upfront planning with the benefits of Agile execution.

How We Helped

Yuval Yeret’s role was pivotal in transforming M:M Bio’s operations. His expertise in Agile transformation provided the framework and support we needed

Here’s what we focused on:

  • Train Leaders and Teams: Deliver comprehensive workshops that introduced the Agile mindset and practical tools tailored for the biotech environment.
  • Facilitate Collaboration: Establish shared practices and communication channels, such as Kanban boards, that bridged gaps between diverse teams.
  • Support Continuous Adaptation: Guide initial cycles and pilots, enabling teams to inspect their progress, adapt quickly, and continuously improve their processes.

By reimagining how M:M Bio managed its R&D projects, Yuval helped create an environment where innovation, transparency, and collaboration drive success in the race to develop life-saving oncology treatments.

To learn more about this unique case study and how I helped, Check out this Scrum.org podcast episode.

SAFe® Business Agility Podcast | The Value of Flow with Yuval Yeret

In this video by Scaled Agile I have a conversation with SAFe Fellow Adam Mattis about Flow, Value Streams, using Flow to drive change management and beyond.

Dreams with Deadlines Yuval Yeret OKRs Business Agility

Exploring the Connection Between Business Agility, OKRs and Private Equity – Interview w/ Yuval on the Quantive Dreams with Deadlines Podcast

If you’re here, you might be interested in OKRs. If so you should check out the Dreams with Deadlines podcast published by Quantive (formerly Gtmhub). I was delighted to accept an invitation to come on the podcast to discuss OKRs, Business Agility, Agile, Evidence-based management and the connection to increasing value creation e.g. in the Private …

Read more

Anrea Nisbet

Andrea Nisbet – Head of People M:M Bio

We wanted to explore using agile methodologies within our Biotech environment. Yuval worked with us to produce a full programme of training and implementing / adapting Scrum with Kanban across our entire ecosystem. Yuval was flexible in his approach, spent time discussing specifics and his coaching and subject matter expertise was invaluable. 18 months later …

Read more

Hansa BioPharma

Coaching the leadership team of a “commercial franchise” on leveraging agile techniques and principles to improve alignment, empowerment, and risk management when introducing a new revolutionary drug to market.

Dyno Therapeutics

I helped the Dyno team evolve their approach to agility beyond mechanical agile towards principled agility applied both to the Tech organization (including Machine-learning, BigData) as well as the Biology teams (creating virus/capsids) , G&A, and the executive team. This included Professional Scrum training, workshops to agree on the next iteration of agility at Dyno …

Read more

Drunk Agile Podcast SAFe, Kanban and Scrum

Yuval Yeret joins Daniel and Prateek for an edgy conversation about where SAFe meets Kanban and Flow. Sparks fly as they discuss SAFe without story points, PI Planning in a flow world, and Cost of Delay.

Cindy Grönberg Moldin – VP Brand – Cotopaxi | Ex P&G

Yuval led the agile training at Gillette, which was linked to a major innovation project we were working on (The Exfoliating Razor). The project was on extreme timing and we needed to rethink how to create innovation without sacrificing quality. Yuval trained us on the basics and then consulted with us to help us define …

Read more

Gillette – Designing and Productizing a New Razor with Scrum

Summary I partnered with Gillette’s R&D and Commercial leadership to leverage Scrum for designing the Gillette Exfoliating Razor. This initiative included several multi-disciplinary teams involving technical, research, and commercial teams collaborating on one scaled Scrum borrowing patterns from the Nexus framework. Using Scrum to quickly learn and validate on the key leap of faith assumptions …

Read more

Aras

Aras’ collaboration with Yuval Yeret propelled them towards agile excellence, yielding rapid innovation, enhanced collaboration, and market responsiveness. The transformation, orchestrated by Yeret, revolutionized Aras’ product development, quality, and operational efficiency.